4
Changes in Ownership
Cytek Biosciences, Inc. Filed Acc 0001209191-22-017217
Chief Technology Officer acquired 73,011 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Yan Ming Chief Technology Officer | 2022-03-07 | Option exercise | +62,456 | $0.25 | $15,614 | 8,152,248 | D |
| Yan Ming Chief Technology Officer | 2022-03-07 | Option exercise | +10,555 | $0.92 | $9,711 | 8,162,803 | D |
| Derivatives | |||||||
| Yan Ming Chief Technology Officer | 2022-03-07 | Option exercise · Stock Option (Right to Buy) | −62,456 | 0 | D | ||
| Yan Ming Chief Technology Officer | 2022-03-07 | Option exercise · Stock Option (Right to Buy) | −10,555 | 16,111 | D | ||
Loading xslF345X03/doc4.xml…